GPR183 and autoimmune disease: The expression of EBI2 and enzymes for 7α, 25-OHC is upregulated in inflammatory diseases, and dysregulation of EBI2 may contribute to B cell malignancies, and certain autoimmune diseases such as T1D, RA, lupus, and MS.